regeneron pharmaceuticals inc
再生元制药(Regeneron Pharmaceuticals Inc)公告四季度公司盈利降至1.74亿美元，上一年同期为2.53亿美元，合每股2.19美元。收入从12.3亿美元升至15.8亿美元。
基于1个网页-相关网页
regeneron pharmaceuticals inc
Regeneron制药公司
以上为机器翻译结果，长、整句建议使用 人工翻译 。
-
Among the largest underlying components of MDY, in trading today Vertex Pharmaceuticals, Inc. ( NASD: VRTX) is up about 0.6%, Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 0.2%, and Equinix Inc ( NASD: EQIX) is lower by about 0.9%.
FORBES: MDY, VRTX, REGN, EQIX: ETF Inflow Alert
-
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is off about 1.2%, Vertex Pharmaceuticals, Inc. ( NASD: VRTX) is up about 0.5%, and Equinix Inc ( NASD: EQIX) is lower by about 1.6%.
FORBES: Noteworthy ETF Inflows: IJH, REGN, VRTX, EQIX
-
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 0.7%, HollyFrontier Corp. ( NYSE: HFC) is up about 0.3%, and AMETEK, Inc. ( NYSE: AME) is up by about 0.5%.
FORBES: Notable ETF Inflow Detected - IJH, REGN, HFC, AME
更多权威例句